Thalidomide-resistant HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor

J Am Acad Dermatol. 1995 Aug;33(2 Pt 2):380-2. doi: 10.1016/0190-9622(95)91439-0.

Abstract

Thalidomide has been advocated as the treatment of choice for recalcitrant aphthae. We describe the case of patient with HIV infection and extensive aphthae whose condition failed to respond to corticosteroids, cyclosporine, and thalidomide. The patient's course was complicated by colonic aphthae. Rapid and sustained resolution was achieved through treatment with granulocyte colony-stimulating factor, a previously unreported therapeutic option.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • HIV Infections / complications*
  • Humans
  • Stomatitis, Aphthous / drug therapy*
  • Stomatitis, Aphthous / virology
  • Thalidomide / therapeutic use*

Substances

  • Granulocyte Colony-Stimulating Factor
  • Thalidomide